November 29, 2017
 

BASF to introduce poultry nutritional solutions to South Asia
 

 

BASF and Vital Therapeutics Pvt. Ltd, a leading manufacturer of vitamin premixes and veterinary formulations in India, have entered a strategic partnership to bring a new choline chloride product to the feed industry in India and the rest of South Asia.

 

Both companies will provide a range of choline chloride powder formulations to address specific market needs. Vital Therapeutics had launched the new choline chloride products at the recent Poultry India Expo in Hyderabad, India.

 

A sufficient supply of choline - which is critical for building lecithin, acetylcholine and ceramides - contributes to a vital and productive flock. Animals can produce certain amounts of choline themselves but it does not suffice to meet their own demand. Therefore, it is beneficial to add choline to feed. The new choline chloride powder feed supplement comes in two formulations: a 60% corn cob-based formulation for application in poultry and dairy; and a 50% silica-based formulation for aquaculture. The new products will be marketed as "Vitachol 50" and "Vitachol 60" by Vital Therapeutics and co-branded with BASF.

 

"This strategic alliance is the beginning of a new level of cooperation between BASF and Vital Therapeutics", said Venugopal Setty, managing director of Vital Therapeutics Pvt. Ltd. "This partnership between BASF and Vital Therapeutics has opened up a new market segment for choline chloride powder formulations while offering the premium product to our customers at competitive price levels to meet their expectations."

 

BASF has also entered into a distribution agreement with Avitech Nutrition Pvt. Ltd., a leader in the field of animal nutrition in India, with expertise in feed additives, especially vitamin and mineral premixes, to extend its organically-bound trace elements (glycinates) product offering to feed producers in South Asia.

 

Trace elements are essential micronutrients required by all animal species. An insufficient supply of trace elements leads to major health and performance-related impairments, for example, reduced feed intake and growth performance, and impaired immune function and fertility.

 

Under the collaboration, glycinate-premixes manufactured by Avitech will contain high-quality of organically-bound trace elements (Copper-glycinate, manganese-glycinate, iron-glycinate and zinc-glycinate) from BASF. The new product will be marketed by Avitech and co-branded with BASF.

 

"Avitech is pleased to represent BASF for its line of organically-bound trace elements (glycinates). As a leader in the area of minerals, our inorganic minerals are employed in over six million tonnes of feed annually. Our local reach, coupled with BASF's global technology, represent a product offering that meets the market need for superior organic minerals," remarked Rahul Kapur, managing director of Avitech Nutrition Pvt. Ltd. "We are excited by the partnership and its potential."

 

"For BASF to be successful in a market, it is important for us to focus on our own strengths and team up with carefully selected partners to complete our offering. With the superior customer contact, market presence and reach of Vital Therapeutics and Avitech Nutrition, BASF will now have the possibility to offer our high-quality products throughout the Indian market," said Stephen Crisp, regional head of BASF Animal Nutrition Asia Pacific.

As the first company to offer a phytase for the global feed market more than 25 years ago, BASF had set a new standard in feed phytase technology with the launch of Natuphos E in 2016.

 

With unprecedented enzyme stability, Natuphos E helps poultry utilsze phosphorous and other key nutrients more efficiently, ensuring more productive and sustainable output for the animal feed industry and local farmers.

 

In addition to glycinates, vitamins and enzymes, BASF had showcased its comprehensive portfolio of products, including organic acids and carotenoids, at the India Poultry Expo.